Why is Fredun Pharma falling/rising?

As of 16-Sep, Fredun Pharmaceuticals Ltd's stock price is rising, currently at 1,250.00, reflecting an increase of 21.05 or 1.71%. The stock has shown a positive trend recently, gaining 2.97% over the last two days despite opening lower today with a loss of 2.16%. In terms of performance against benchmarks, the stock has outperformed its sector by 1.43% today, although it has underperformed the Sensex over the past week with a decline of 1.57%. Notably, the company has demonstrated strong long-term growth, with net sales increasing at an annual rate of 38.16% and operating profit at 56.18%. The stock's attractive valuation, trading at a discount compared to peers, and consistent positive quarterly results contribute to its upward momentum.
In the broader market context, while the stock has generated a remarkable return of 57.43% over the past year, the benchmark BSE500 has faced negative returns of -2.93%. This stark contrast highlights the stock's resilience and market-beating performance. However, the recent decline in investor participation, with delivery volume dropping significantly, raises concerns about the stock's liquidity and investor confidence. Additionally, the lack of domestic mutual fund investment may indicate caution among institutional investors regarding the stock's valuation or business prospects. Overall, while the stock is currently rising, these factors suggest a complex landscape that could influence future price movements.